DBV Technologies | DBVT - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
DBV Technologies USD 274M 17M 2025-09
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 8.56B 905M 2026-05
Incyte USD 21.73B 3B 2026-05
Insmed USD 15.56B 19.73B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Sarepta Therapeutics USD 2.16B 123M 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05